Reuters logo
6 months ago
BRIEF-Auris medical receives FDA fast track designation for AM-111 in acute sensorineural hearing loss
February 24, 2017 / 1:56 PM / 6 months ago

BRIEF-Auris medical receives FDA fast track designation for AM-111 in acute sensorineural hearing loss

Feb 24 (Reuters) - Auris Medical Holding Ag

* Auris Medical receives FDA fast track designation for AM-111 in acute sensorineural hearing loss

* Auris Medical expects to announce top-line results from ASSENT trial in second half of 2018

* Expects to complete enrollment in Q2'17, announce top-line results in Q3'17 for HEALOS AM-111 trial Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below